Leukocyte Telomere Length and Its Interaction with Germline Variation in Telomere-Related Genes in Relation to Pancreatic Adenocarcinoma Risk
Open Access
- 20 April 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 29 (7), 1492-1500
- https://doi.org/10.1158/1055-9965.epi-19-1597
Abstract
Leukocyte telomere length (LTL) has been associated with risk of multiple cancers, but its association with pancreatic ductal adenocarcinoma (PDAC) is unclear. We therefore investigated the association between peripheral blood LTL and PDAC risk, and examined effect modification by candidate SNPs previously reported to be associated with variation in LTL. A case–control study of 1,460 PDAC cases and 1,459 frequency-matched controls was performed using biospecimens and data from the Mayo Clinic Biospecimen Resource for Pancreas Research. Quantitative PCR was used to measure LTL and categorized into tertiles based on sex-specific control distribution. Eleven telomere-related SNPs also were genotyped. Logistic regression was used to calculate ORs and 95% confidence intervals (CI). Shorter peripheral blood LTL was associated with a higher risk of PDAC (ORT1vsT3 = 1.26, 95% CI = 1.03–1.54, Ptrend = 0.02; ORcontinuous = 1.14, 95% CI = 1.02–1.28), but the association was restricted to cases with treatment-naïve blood samples (ORT1vsT3 = 1.51, 95% CI = 1.16–1.96, Ptrend = 0.002; ORcontinuous = 1.25, 95% CI = 1.08–1.45) and not cases whose blood samples were collected after initiation of cancer therapy (ORT1vsT3 = 1.10, 95% CI = 0.87–1.39, Ptrend = 0.42; ORcontinuous = 1.08, 95% CI = 0.94–1.23). Three SNPs (TERC-rs10936599, ACYP2-rs11125529, and TERC-rs1317082) were each associated with interindividual variation in LTL among controls, but there was no evidence of effect modification by these SNPs. Treatment-naïve short LTL is associated with a higher risk of PDAC, and the association does not differ by germline variation in the candidate telomere-related SNPs examined. Peripheral blood LTL might serve as a molecular marker for risk modeling to identify persons at high risk of PDAC.Keywords
Funding Information
- NCI (P50CA102701)
This publication has 45 references indexed in Scilit:
- A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer riskHuman Molecular Genetics, 2013
- Telomeres shorten at equivalent rates in somatic tissues of adultsNature Communications, 2013
- Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humansHuman Molecular Genetics, 2012
- Physical Activity, Sedentary Behavior, and Leukocyte Telomere Length in WomenAmerican Journal of Epidemiology, 2012
- Epidemiologic evidence for a role of telomere dysfunction in cancer etiologyMutation Research - Reviews in Mutation Research, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasiasLaboratory Investigation, 2011
- Telomeres and telomerase in cancerCarcinogenesis: Integrative Cancer Research, 2009
- The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancerAging Cell, 2009
- Obesity and Weight Gain in Adulthood and Telomere LengthCancer Epidemiology, Biomarkers & Prevention, 2009